Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis

Noah Lechtzin, Charles M. Wiener, Lora Clawson, Matthew C. Davidson, Fred Anderson, Neelam Gowda, Gregory B. Diette

Research output: Contribution to journalArticle

Abstract

Introduction: Noninvasive positive pressure ventilation (NIPPV) is associated with improved survival in amyotrophic lateral sclerosis (ALS) and has been widely recommended. The extent of NIPPV use in ALS patients and the factors associated with its use have not been studied. Methods: A cross-sectional study using the ALS Patient Care Database. Analyses were performed to assess the association of patient and care characteristics with use of ventilatory support. Results: 1458 patients were studied. 15.6% used NIPPV and 2.1% used invasive mechanical ventilation. Patients who used NIPPV were significantly more likely to be male and have higher income than those who did not. They were also more likely to have a gastrostomy tube, lower vital capacity, more severe disease, bulbar involvement and poorer general health status as measured by the SF-12 and Sickness Impact Profile. Multivariate analysis revealed that lower FVC, higher income and use of gastrostomy tube were independently associated with use of NIPPV. Conclusions: NIPPV is used more than seven times as frequently as invasive ventilation in ALS patients. Patients who use NIPPV have more severe disease than those who do not use any respiratory intervention. Patients with lower income are less likely to use NIPPV, which raises concerns about disparities in the care of patients with ALS.

Original languageEnglish (US)
Pages (from-to)9-15
Number of pages7
JournalAmyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Volume5
Issue number1
DOIs
StatePublished - Mar 1 2004

Keywords

  • Amyotrophic lateral sclerosis
  • BiPAP
  • Non-invasive ventilation
  • Tracheostomy

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

  • Cite this